Annovis Bio (ANVS) Earnings Date & Reports

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANVS is expected to report earnings to rise 49.22% to -47 cents per share on August 13

Q2'25

Est.

$-0.48

Q1'25

Beat

by $0.06

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.46

Q2'24

Beat

by $0.19

The last earnings report on May 13 showed earnings per share of -31 cents, beating the estimate of -37 cents. With 251.41K shares outstanding, the current market capitalization sits at 33.13M.

View a ticker or compare two or three

Compare

ANVS